Irritable Bowel Syndrome Therapy Removed From Market (Again) Irritable Bowel Syndrome Therapy Removed From Market (Again)

Zelnorm, a short-term IBS-C treatment, has been removed from the market. The drug manufacturer cited ' business concerns. 'News Alerts
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news